Reflections on NHS England's OTC prescribing ban.
- Published in:
- Prescriber, 2018, v. 29, n. 9, p. 38, doi. 10.1002/psb.1706
- By:
- Publication type:
- Article
Works matching IS 09596682 AND DT 2018 AND VI 29 AND IP 9
Results: 8
1
2
Ocrelizumab for relapsing or primary progressive MS.
- Published in:
- Prescriber, 2018, v. 29, n. 9, p. 35, doi. 10.1002/psb.1705
- By:
- Publication type:
- Article
3
Management of systemic lupus erythematosus in adults.
- Published in:
- Prescriber, 2018, v. 29, n. 9, p. 31, doi. 10.1002/psb.1704
- By:
- Publication type:
- Article
4
Online consultations: the future of NHS GP appointments?
- Published in:
- Prescriber, 2018, v. 29, n. 9, p. 27, doi. 10.1002/psb.1703
- By:
- Publication type:
- Article
5
The NHS at 70: five key questions answered.
- Published in:
- Prescriber, 2018, v. 29, n. 9, p. 23, doi. 10.1002/psb.1702
- By:
- Publication type:
- Article
6
Recommended drug therapies for inflammatory bowel disease.
- Published in:
- Prescriber, 2018, v. 29, n. 9, p. 17, doi. 10.1002/psb.1701
- By:
- Publication type:
- Article
7
Are patients taking pot luck with cannabis?
- Published in:
- Prescriber, 2018, v. 29, n. 9, p. 12, doi. 10.1002/psb.1700
- By:
- Publication type:
- Article
8
Online consultations: no substitute for face‐to‐face appointments.
- Published in:
- Prescriber, 2018, v. 29, n. 9, p. 4, doi. 10.1002/psb.1699
- By:
- Publication type:
- Article